文献速递脑血管病

高血清脑源性神经营养因子与缺血性卒中后不良预后风险降低相关

High Serum Brain-Derived Neurotrophic Factor Is Associated With Decreased Risks of Poor Prognosis After Ischemic Stroke.
PubMed 文献 · Stroke · 2023-06-06

这项多中心前瞻性队列研究纳入3319例缺血性卒中患者,检测血清BDNF水平并随访3个月。校正混杂因素后,较高血清BDNF水平与主要结局、主要残疾、死亡及死亡和血管事件复合结局风险降低相关,提示BDNF可能是缺血性卒中预后生物标志物。

要点

  • 血清BDNF较高与3个月主要结局风险降低相关(OR 0.73,95%CI 0.58-0.93)。
  • 较高BDNF与主要残疾、死亡及死亡和血管事件复合结局风险降低相关。
  • BDNF加入常规危险因素可轻微改善主要结局的重分类。

核心结论

  • 升高的血清BDNF浓度与缺血性卒中后不良结局风险降低独立相关,提示血清BDNF可能是缺血性卒中后预后的潜在生物标志物。

研究设计与样本

  • 前瞻性多中心队列研究,纳入中国26家医院2009年8月至2013年5月间的3319例缺血性卒中患者,检测血清BDNF浓度。
  • 主要结局为卒中发病后3个月死亡和主要残疾(改良Rankin量表评分≥3)的复合结局。
  • 采用多因素logistic回归或Cox比例风险回归分析评估血清BDNF水平与不良临床结局的关联。

主要发现

  • 3个月随访期间,827例(24.92%)患者发生主要结局,包括734例主要残疾和93例死亡。
  • 校正年龄、性别及其他重要预后因素后,比较血清BDNF水平最高与最低三分位组,升高与主要结局风险降低相关(OR 0.73,95%CI 0.58-0.93)。
  • 比较最高与最低三分位组,升高与主要残疾风险降低相关(OR 0.78,95%CI 0.62-0.99)。
  • 比较最高与最低三分位组,升高与死亡风险降低相关(HR 0.55,95%CI 0.32-0.97)。
  • 比较最高与最低三分位组,升高与死亡和血管事件复合结局风险降低相关(HR 0.61,95%CI 0.40-0.93)。

关键数值与推荐

  • 多变量校正样条回归分析显示血清BDNF水平与主要结局呈线性关联(线性检验P=0.005)。
  • 将BDNF加入常规危险因素对主要结局的重分类有轻微改善(净重分类改善19.33%,P<0.001;综合判别指数0.24%,P=0.011)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文结论指出需进一步研究以探讨BDNF对缺血性卒中的潜在治疗获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: BDNF (brain-derived neurotrophic factor) has been implicated in cardiovascular homeostasis and ischemic stroke pathogenesis. We aimed to prospectively investigate the associations between serum BDNF levels and the prognosis of ischemic stroke in a multicenter cohort study. METHODS: This prospective study follows the STROBE reporting guideline. Serum BDNF concentrations were measured in 3319 ischemic stroke patients from the China Antihypertensive Trial in Acute Ischemic Stroke between August 2009 and May 2013 in 26 hospitals across China. The primary outcome was the composite outcome of death and major disability (modified Rankin Scale score ≥3) at 3 months after stroke onset. Multivariate logistic regression or Cox proportional hazards regression analysis was used to assess the associations between serum BDNF levels and adverse clinical outcomes. RESULTS: During the 3-month follow-up period, 827 (24.92%) patients experienced a primary outcome, including 734 major disabilities and 93 deaths. After adjusting for age, sex, and other important prognostic factors, elevated serum BDNF levels were associated with decreased risks of primary outcome (odds ratio, 0.73 [95% CI, 0.58-0.93]), major disability (odds ratio, 0.78 [95% CI, 0.62-0.99]), death (hazard ratio, 0.55 [95% CI, 0.32-0.97]), and the composite outcome of death and vascular events (hazard ratio, 0.61 [95% CI, 0.40-0.93]) when 2 extreme tertiles were compared. Multivariable-adjusted spline regression analyses showed a linear association between serum BDNF levels and the primary outcome (P value for linearity=0.005). The addition of BDNF to conventional risk factors slightly improved reclassification for the primary outcome (net reclassification improvement: 19.33%; P<0.001; integrated discrimination index: 0.24%; P=0.011). CONCLUSIONS: Elevated serum BDNF concentrations were independently associated with decreased risks of adverse outcomes after ischemic stroke, suggesting that serum BDNF may be a potential biomarker for prognosis after ischemic stroke. Further studies are warranted to investigate the potential therapeutic benefit of BDNF for ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Zhu Y, Sun L, Huang T, et al. High Serum Brain-Derived Neurotrophic Factor Is Associated With Decreased Risks of Poor Prognosis After Ischemic Stroke. Stroke. 2023. PMID: 37278235. doi:10.1161/STROKEAHA.122.042362

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。